“Combine Impact of Shatavari and Shatpushpi on Polycyclic ovarian syndrome (PCOS)”, Journal of Pharmaceutical Negative Results, pp. 431–437, Oct. 2022, doi: 10.47750/pnr.2022.13.S06.060.